UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B

Journal of gastroenterology and hepatology, 2010-09, Vol.25 (9), p.1569-1577

2010

Volltextzugriff (PDF)

Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey

World journal of gastroenterology : WJG, 2003-05, Vol.9 (5), p.1106

2003

Volltextzugriff (PDF)

Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis

World journal of gastroenterology : WJG, 2006-02, Vol.12 (8), p.1292

2006

Volltextzugriff (PDF)

Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy

World journal of gastroenterology : WJG, 2007-06, Vol.13 (21), p.3003

2007

Volltextzugriff (PDF)

CSH guidelines for the diagnosis and treatment of drug-induced liver injury

Hepatology international, 2017-05, Vol.11 (3), p.221-241

2017

Volltextzugriff (PDF)

Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes

Experimental & molecular medicine, 2017-01, Vol.49 (1), p.e283-e283

2017

Volltextzugriff (PDF)

Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial

World journal of gastroenterology : WJG, 2003-11, Vol.9 (11), p.2480

2003

Volltextzugriff (PDF)

Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study

World journal of gastroenterology : WJG, 2004-11, Vol.10 (22), p.3269

2004

Volltextzugriff (PDF)

Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters

World journal of gastroenterology : WJG, 2003-11, Vol.9 (11), p.2574

2003

Volltextzugriff (PDF)

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

Hepatology (Baltimore, Md.), 2005-12, Vol.42 (6), p.1437-1445

2005

Volltextzugriff (PDF)

Cholesterol metabolism and expression of its relevant genes in cultured steatotic hepatocytes

Journal of digestive diseases, 2009-11, Vol.10 (4), p.310-314

2009

Volltextzugriff (PDF)

Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo‐controlled phase 2 trial

Journal of digestive diseases, 2018-03, Vol.19 (3), p.144-154

2018

Volltextzugriff (PDF)

Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice

World journal of gastroenterology : WJG, 2004-04, Vol.10 (8), p.1176

2004

Volltextzugriff (PDF)

Relationship between clinical and pathologic findings in patients with chronic liver diseases

World journal of gastroenterology : WJG, 2003-12, Vol.9 (12), p.2796

2003

Volltextzugriff (PDF)

Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)

Journal of digestive diseases, 2019-04, Vol.20 (4), p.163-173

2019

Volltextzugriff (PDF)

Validation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis

Zhonghua gan zang bing za zhi, 2011-10, Vol.19 (10), p.782

2011

Volltextzugriff (PDF)

Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study

Zhonghua gan zang bing za zhi, 2009-11, Vol.17 (11), p.847

2009

Volltextzugriff (PDF)

Glucotoxicity, lipotoxicity and the nonalcoholic fatty liver disease

Zhonghua gan zang bing za zhi, 2005-02, Vol.13 (2), p.81

Zeng, Min-de

2005

Volltextzugriff (PDF)

Evaluation of noninvasive diagnoses of hepatic fibrosis

Zhonghua gan zang bing za zhi, 2008-03, Vol.16 (3), p.165

2008

Volltextzugriff (PDF)

Obesity and liver fibrosis

Zhonghua gan zang bing za zhi, 2004-07, Vol.12 (7), p.432

Zeng, Min-De

2004

Volltextzugriff (PDF)

Abstinence: the best way to control alcoholic liver diseases

Zhonghua gan zang bing za zhi, 2003-11, Vol.11 (11), p.645

Zeng, Min-de

2003

Volltextzugriff (PDF)

General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease

Zhonghua gan zang bing za zhi, 2011-05, Vol.19 (5), p.362

2011

Volltextzugriff (PDF)

Evaluation of blood panel markers in the diagnosis of hepatic fibrosis

Zhonghua gan zang bing za zhi, 2008-03, Vol.16 (3), p.163

2008

Volltextzugriff (PDF)

Capsule metadoxine in the treatment of alcoholic liver disease: a randomized, double-blind, placebo-controlled, multicenter study

Zhonghua gan zang bing za zhi, 2009-03, Vol.17 (3), p.213

2009

Volltextzugriff (PDF)

Non-invasive diagnosis of hepatic fibrosis

Zhonghua gan zang bing za zhi, 2006-03, Vol.14 (3), p.210

2006

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(31)

Publikationsform

Sprache

Englisch
(51)
Chinesisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B

Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey

Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis

Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy

CSH guidelines for the diagnosis and treatment of drug-induced liver injury

Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes

Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial

Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study

Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

Cholesterol metabolism and expression of its relevant genes in cultured steatotic hepatocytes

Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo‐controlled phase 2 trial

Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice

Relationship between clinical and pathologic findings in patients with chronic liver diseases

Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)

Validation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis

Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study

Glucotoxicity, lipotoxicity and the nonalcoholic fatty liver disease

Evaluation of noninvasive diagnoses of hepatic fibrosis

Obesity and liver fibrosis

Abstinence: the best way to control alcoholic liver diseases

General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease

Evaluation of blood panel markers in the diagnosis of hepatic fibrosis

Capsule metadoxine in the treatment of alcoholic liver disease: a randomized, double-blind, placebo-controlled, multicenter study

Non-invasive diagnosis of hepatic fibrosis

Suchergebnisse filtern